Trial Studied treatment Control Patients Size Study type Results NCT

Heart failure - phosphodiesterase III inhibitors in all type of patients

Cowley, 1994Enoximoneplacebo151 (75/76)
EMOTE, 2007enoximoneplacebo201 (101/100)
EMTG, 1990Enoximoneplacebo102 (50/52)
ESG, 2000Enoximoneplacebo105 (70/35)
ESSENTIAL (I and II), 2009enoximoneplacebo1854 (926/928) Confirmatory NCT00051285
Lardoux, 1987Enoximoneplacebo43 (30/13)
WESG, 1991Enoximoneplacebo164 (108/56)
EMPOWER ongoing enoximoneplacebo (on top metoprolol)NA NCT00077948